Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
3
×
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
deals
drugs
investing
otsuka pharmaceutical
venture capital
4d molecular therapeutics
abbvie
accent therapeutics
acne
What
bio
fda
3
×
roundup
3
×
activity
ahead
approvals
approved
asco
biogen
branded
choices
clamped
commissioner
companies
consumers
costly
counterweight
covid
delays
developing
digital
disease
drug
drugs
economic
elevatebio
epidemic
fast
fatty
frenzied
generic
graft
growing
including
ipo
isn’t
known
led
liver
lot
Language
unset
Current search:
roundup
×
cancer
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
